Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 116 matching records.
116 results — page 1 of 5
- Level BClinical TrialPubMed
Clinical efficacy and safety of allogeneic adipose-derived stem cells ELIXCYTE in chronic kidney disease: a phase I/II study.
Clinical Trial on Chronic Kidney Disease, published in Stem Cells Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cells Transl Med - Level BClinical TrialPubMed
Safety and feasibility of intravenous fresh adipose-derived mesenchymal stem cells in secondary progressive multiple sclerosis: phase I/IIa clinical results.
Clinical Trial on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther1 citations - Level BClinical TrialPubMed
Acellular Adipose Tissue promotes anti-fibrotic remodeling in Phase II Study.
Clinical Trial on Chronic Inflammation, published in medRxiv (2026) — summary generated from the PubMed abstract.
- 2026
medRxiv - Level BClinical TrialPubMed
Autologous SVF therapy modulates neuroinflammation in ALS: phase I trial demonstrating safety and CSF biomarker dynamics.
Clinical Trial with a reported sample of 26 on Neuroinflammation, Immune Modulation, published in Front Aging Neurosci (2026) — summary generated from the PubMed abstract.
- 2026
- n = 26
Front Aging Neurosci - Level BClinical TrialEurope PMC
An open phase I/IIa study evaluating safety, patient-reported outcomes and voice function after surgery, local administration of mesenchymal stromal cells and voice training in patients with vocal fold scarring and dysph
Clinical Trial on Scar, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Res Ther - Level BClinical TrialEurope PMC
Intravenous human umbilical cord-derived mesenchymal stem cell transplantation for ischemic stroke (MERIT): A phase 1 trial
Clinical Trial with a reported sample of 6 on Stroke Research, published in Cell Rep Med (2026) — summary generated from the PubMed abstract.
- 2026
- n = 6
Cell Rep Med - Level BClinical TrialPubMed
Preclinical safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell medicinal product for rotator cuff repair: a two-phase experimental study.
Clinical Trial with a reported sample of 24 on Tendon Injury, Rotator Cuff, published in J Shoulder Elbow Surg (2026) — summary generated from the PubMed abstract.
- 2026
- n = 24
J Shoulder Elbow Surg - Level BClinical TrialPubMed
Decellularised Corneal Stromal Lamina With or Without Autologous Adipose-Derived Adult Stem Cells for Advanced Keratoconus: 1-Year Results of a Phase I/IIa Clinical Trial.
Clinical Trial with a reported sample of 5, published in Clin Exp Ophthalmol (2026) — summary generated from the PubMed abstract.
- 2026
- n = 5
Clin Exp Ophthalmol - Level BClinical TrialPubMed
Long-term Effectiveness and Safety of Mesenchymal Stromal Cell Therapy for Radiation-Induced Hyposalivation in Head and Neck Cancer Survivors: A Randomized Phase II Trial.
Clinical Trial, published in Clin Cancer Res (2025) — summary generated from the PubMed abstract.
- 2025
Clin Cancer Res3 citations - Level BClinical TrialEurope PMC
Effects of Combined Intrathecal Mesenchymal Stem Cells and Schwann Cells Transplantation on Neuropathic Pain in Complete Spinal Cord Injury: A Phase II Randomized Active-Controlled Trial
Clinical Trial on Spinal Cord Injury, published in Cell Transplant (2025) — summary generated from the PubMed abstract.
- 2025
Cell Transplant8 citations - Level BClinical TrialPubMed
A Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia.
Clinical Trial on Ankle Injury, Peripheral Artery Disease, Chronic Wound, published in Int J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
Int J Stem Cells - Level BClinical TrialPubMed
Safety and efficacy of long-shelf-life allogeneic adipose-derived mesenchymal stem cell line-derived platelet-like cells for refractory foot ulcers: A translational preclinical and phase 1/2a study.
Clinical Trial on Chronic Wound, published in Regen Ther (2025) — summary generated from the PubMed abstract.
- 2025
Regen Ther - Level BRandomized Controlled TrialPubMed
Effect of intra-articular adipose-derived mesenchymal stromal cell versus placebo injection on pain and function in patients with knee osteoarthritis: the ADIPOA2 phase 2b randomised clinical trial.
Randomized Controlled Trial with a reported sample of 26 on Knee Osteoarthritis, Osteoarthritis, published in Ann Rheum Dis (2025) — summary generated from the PubMed abstract.
- 2025
- n = 26
Ann Rheum Dis - Level BClinical TrialEurope PMC
Safety of autologous nucleus pulposus cell transplantation with fibrin glue following endoscopic discectomy in chronic low back pain: a preliminary phase I trial
Clinical Trial on Back Pain, Disc Degeneration, published in BMC Musculoskelet Disord (2025) — summary generated from the PubMed abstract.
- 2025
BMC Musculoskelet Disord - Level BRandomized Controlled TrialPubMed
Adipose-derived mesenchymal stem cells for the treatment of Amyotrophic Lateral Sclerosis. A phase I/II safety and efficacy clinical trial.
Randomized Controlled Trial with a reported sample of 40 on Neuroinflammation, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
- n = 40
Front Neurol - Level BClinical TrialEurope PMC
Human umbilical cord mesenchymal stromal cells derivatives in treating diabetic foot ulcers: a phase I/II safety and efficacy trial
Clinical Trial on Type 2 Diabetes, Diabetic Foot, Chronic Wound, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level BClinical TrialPubMed
Efficacy and safety of autologous adipose-derived stem cells in subjects with moderate to severe atopic dermatitis: a multicenter, randomized, single-blind, placebo-controlled, phase 2 trial.
Clinical Trial with a reported sample of 114 on Scar, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
- n = 114
Stem Cell Res Ther - Level BClinical TrialPubMed
Rationale and design of the AlloFIST trial: a phase I/IIa study to evaluate dose escalation of allogeneic adipose-derived stroma/stem cells for the treatment of Crohn's fistula.
Clinical Trial on Osteoarthritis, Chronic Wound, Chronic Inflammation, Autoimmune Research, published in BMJ Open (2025) — summary generated from the PubMed abstract.
- 2025
BMJ Open - Level BClinical TrialEurope PMC
Cell-Based Therapy by Autologous Bone Marrow-Derived Mononuclear Cells for Bone Augmentation of Plate-Stabilized Proximal Humeral Fractures: A Multicentric, Randomized, Open Phase IIa study
Clinical Trial with a reported sample of 56 on Shoulder, published in Stem Cells Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
- n = 56
Stem Cells Transl Med12 citations - Level BClinical TrialPubMed
Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial.
Clinical Trial with a reported sample of 10 on Spinal Cord Injury, published in Nat Commun (2024) — summary generated from the PubMed abstract.
- 2024
- n = 10
Nat Commun75 citations - Level BClinical TrialPubMed
Safety and efficacy of autologous adipose tissue-derived stem cell transplantation in aging-related low-grade inflammation patients: a single-group, open-label, phase I clinical trial.
Clinical Trial on Type 2 Diabetes, Neuroinflammation, Immune Modulation, published in Trials (2024) — summary generated from the PubMed abstract.
- 2024
Trials - Level BClinical TrialEurope PMC
Stem cell therapy in diabetic men with erectile dysfunction: a 24-month follow-up of safety and efficacy of two intracavernous autologous bone marrow derived mesenchymal stem cells injections, an open label phase 2 clini
Clinical Trial, published in Basic Clin Androl (2024) — summary generated from the PubMed abstract.
- 2024
Basic Clin Androl2 citations - Level BRandomized Controlled TrialPubMed
No Clinical Efficacy of Adipose-Derived Regenerative Cells and Lipotransfer in Breast Cancer-Related Lymphedema: A Double-Blind Placebo-Controlled Phase II Trial.
Randomized Controlled Trial, published in Plast Reconstr Surg (2024) — summary generated from the PubMed abstract.
- 2024
Plast Reconstr Surg4 citations - Level BRandomized Controlled TrialPubMed
Safety and therapeutic potential of allogeneic adipose-derived stem cell spray transplantation in ischemic cardiomyopathy: a phase I clinical trial.
Randomized Controlled Trial with a reported sample of 3 on Cardiovascular Disease, published in J Transl Med (2024) — summary generated from the PubMed abstract.
- 2024
- n = 3
J Transl Med7 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406